Drug Trial Results: Positive clinical trial data typically boosts investor confidence and drives up the stock price. Conversely, negative or inconclusive results can lead to a significant price drop.

Regulatory Approvals: Approval from regulatory bodies like the FDA is crucial for commercialization. Approval news usually causes the stock to soar, while rejection can have the opposite effect.

Competition: The emergence of competing therapies or technologies can put downward pressure on BTAI's stock price, especially if those alternatives prove more effective or cost-efficient.

Market Sentiment: Overall market trends and investor sentiment towards the biotechnology sector can influence BTAI's stock price. A bullish market typically benefits biotech stocks.

Financial Performance: BTAI's cash reserves, burn rate, and ability to secure funding impact investor perception. Strong financial health can boost confidence.

Partnerships & Acquisitions: Strategic partnerships or potential acquisitions by larger pharmaceutical companies can significantly increase BTAI's stock value.

Key Personnel Changes: Changes in leadership, particularly the departure of key scientists or executives, can create uncertainty and affect investor confidence.